drugset / Trial / NCT03127943

Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine

NCT03127943 ↗

Phase 4 Completed 24 enrolled University of North Carolina, Chapel Hill
RandomizedCrossoverDouble-blindTreatment

Summary

Assess the clinical impact of Buffered 1% lidocaine with epinephrine as compared to the Non-buffered 1% lidocaine with epinephrine in dental and oral surgical procedures.

Timeline

Start
2017-05-01
Primary completion
2018-04-01
Completion
2018-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 1 % Other

Indications

No indication recorded.